Foresite Capital Opportunity Management V, LLC's Net Worth

$140 Million

Estimate Recalculated Jul 10, 2024 03:16PM EST

Who is Foresite Capital Opportunity Management V, LLC?

Foresite Capital Opportunity Management V, LLC has an estimated net worth of $140 Million. This is based on reported shares across multiple companies, which include Kinnate Biopharma Inc., PARDES BIOSCIENCES, INC., Theseus Pharmaceuticals, Inc., and Gemini Therapeutics, Inc. /DE.

SEC CIK

Foresite Capital Opportunity Management V, LLC's CIK is 0001792207

Past Insider Trading and Trends

2023 was Foresite Capital Opportunity Management V, LLC's most active year for acquiring shares with 10 total transactions. Foresite Capital Opportunity Management V, LLC's most active month to acquire stocks was the month of November. 2020 was Foresite Capital Opportunity Management V, LLC's most active year for disposing of shares, totalling 9 transactions. Foresite Capital Opportunity Management V, LLC's most active month to dispose stocks was the month of November. 2021 saw Foresite Capital Opportunity Management V, LLC paying a total of $28,250,000.00 for 23,402,822 shares, this is the most they've acquired in one year. In 2023 Foresite Capital Opportunity Management V, LLC cashed out on 16,813,146 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PARDES BIOSCIENCES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.99%
-16.81M
—
—
1K
Aug 31
Form 4
+9.68%
773.95K
$1.50
$1,160,928.00
8.77M
Apr 5
Form 4/A
—
0
—
—
0
Dec 23
Form 4/A
∞
4.94M
—
—
4.94M
Dec 23
Form 4
∞
13.63M
$10.00
$10,000,000.00
13.63M
Dec 23
Form 4
∞
325K
$10.00
$3,250,000.00
325K
Dec 22
Form 3
—
0
—
—
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+14.60%
700K
$2.97
$2,079,000.00
5.49M
Jul 17
Form 4
+11.64%
500K
$5.00
$2,500,000.00
4.79M
Dec 29
Form 3
—
0
—
—
0
No matching records found

Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.72M
—
—
0
Apr 3
Form 4
+78.53%
1.78M
$2.80
$4,984,000.00
4.05M
May 8
Form 4
+125.71%
1.1M
—
—
1.98M
Feb 17
Form 4
+983.83%
9.84M
—
—
10.84M
Dec 7
Form 4
∞
1M
$20.00
$20,000,000.00
1M
Dec 3
Form 3
—
0
—
—
0
No matching records found

Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $65.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.43M
$10.00
$15,000,000.00
4.43M
Feb 5
Form 3
—
0
—
—
0
No matching records found

ALUMIS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
13.98M
$16.00
$40,000,000.00
13.98M
Jul 1
Form 3
—
0
—
—
0
No matching records found